Clinical Trial: A Phase 1b Study Comparing the Pharmacokinetics and Safety of Low- and High-Dose BIOPIN Naltrexone Implants With Monthly Vivitrol Injections in Healthy Volunteers Over 12 Months

U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07064564) titled 'A Phase 1b Study Comparing the Pharmacokinetics and Safety of Low- and High-Dose BIOPIN Naltrexone Implants With Monthly Vivitrol Injections in Healthy Volunteers Over 12 Months' on July 05.

Brief Summary: This is a Phase 1b clinical study testing a new extended-release implant that delivers naltrexone, a medication used to treat opioid use disorder (OUD). The investigational product is called BIOPIN. It is a small implant that is inserted just under the skin of the thigh and slowly releases medication over many months. The goal of the study is to see what the blood levels of naltrexone are from two different doses of the BIOPIN imp...